Thorough QT Assessment of Cedazuridine in Healthy Subjects

Clinical trial NCT04953923 · COMPLETED

Trial details

NCT number: NCT04953923
Sponsor: Astex Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2021-07-01
Primary completion: 2021-11-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.